Biotech Investing: World

Coverage of the biotech market for global investors, including news, analysis forecasts, and stock updates.

Scientist pouring blue liquid from a test tube into a flask in a lab.

Biotech Market Forecast: Top Trends for Biotech in 2026

What's the outlook for biotech in 2026? Learn about the sector's key growth drivers, and find out which technologies and catalysts are set to disrupt the traditional R&D model and deliver durable expansion.

Biotech Investing
Latest Articles

Top 5 Small-cap Biotech Stocks of 2025

Biotech Investing

Top 4 Canadian Biotech Stocks of 2025

Biotech Investing

5 Small-cap Biotech ETFs to Watch

Biotech Investing

Transforming Disease Detection with AI-Driven Biological Insights

Biotech Investing

Biotech and Pharma Market Update: Q3 2025 in Review

Life Science Investing

Top 4 Canadian Biotech Stocks (Updated October 2025)

Biotech Investing
Company Profiles
CRDL:CC

Cardiol Therapeutics

Heal the heart with innovative science.

Pharmaceutical Investing
IVX:AU

Invion Limited

Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases

Biotech Investing
CDX:AU

Cardiex Limited

Biomarker technologies and digital solutions to address the world’s largest health disorders.

Biotech Investing
More Companies
CEO Interviews
Badge
Invion Limited
Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases
SPONSORED/ Invion Limited

Invion Advances Global Strategy With New Licencing Agreement

Pharmaceutical Investing
Badge
Invion Limited
Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases
SPONSORED/ Invion Limited

New Deal Could Spark Invion’s Entry into Pet Cancer Market, CEO Says

Pharmaceutical Investing
Badge
Invion Limited
Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases
SPONSORED/ Invion Limited

Invion CEO Maps Path to Peer-level Valuation as Momentum for Cancer Treatment Trials Builds

Pharmaceutical Investing
biotech News
Invion Limited (ASX:IVX)

Hanlim & Korean Government Fund Pathway to Clinical Trial

Pharmaceutical Investing
Invion Limited (ASX:IVX)

Invion Secures Expanded Photosoft Global Exclusive License

Pharmaceutical Investing
Nextech3D.ai (CSE:NTAR)

Nextech3D.ai Announces Definitive Agreement to Acquire 100% of ARway, Streamlining Operations

Artificial Intelligence Investing
Cardiol Therapeutics (TSX:CRDL)

New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions

Biotech Investing
Nextech3D.ai (CSE:NTAR)

Nextech3D.ai Accelerates Eventdex Integration; Expands AI Matchmaking and Achieves Milestone Production of 800 Interactive Floor Plans in 2025

Artificial Intelligence Investing
Nextech3D.ai (CSE:NTAR)

Nextech3D.ai Poised for Growth as Event-Tech and 3D/AR Revenue Accelerates

Emerging Technology Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040

Biotech Investing
Nextech3D.ai (CSE:NTAR)

Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys

Artificial Intelligence Investing
Nextech3D.ai (CSE:NTAR)

Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys

Artificial Intelligence Investing
Nextech3D.ai (CSE:NTAR)

Nextech3D.ai and Arway Provide Business Combination Update

Artificial Intelligence Investing
Nextech3D.ai (CSE:NTAR)

Nextech3D.ai Provides Update on Toggle3D.ai

Artificial Intelligence Investing
Nextech3D.ai (CSE:NTAR)

Nextech3D.ai Provides Update on Toggle3D.ai

Artificial Intelligence Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

Biotech Investing
Nextech3D.ai (CSE:NTAR)

Nextech3D.ai: Disrupting the Global Events Management Industry with AI and Blockchain

Emerging Technology Investing
Invion Limited (ASX:IVX)

Appendix 4C and Quarterly Activities Report - September 2025

Pharmaceutical Investing
More biotech News
Editors' Picks
Life Science Investing

Biotech and Pharma Market Update: Q2 2025 in Review

Life Science Investing

How AI is Poised to Rewire the Foundations of Medicine

Life Science Investing

Biotech and Pharma Market Update: Q1 2025 in Review

Latest biotech News

More biotech News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES